OncoMatch

OncoMatch/Clinical Trials/NCT06448026

Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma

Is NCT06448026 recruiting? Yes, currently enrolling (Sep 2026). This Phase 2 trial studies multiple treatments including Cemiplimab and Cetuximab for locally recurrent oral cavity squamous cell carcinoma.

Phase 2RecruitingM.D. Anderson Cancer CenterNCT06448026Data as of Sep 2026

Treatment: Cemiplimab · CetuximabTo learn if giving cemiplimab and cetuximab before salvage surgery can help to control recurrent oral cavity squamous cell carcinoma.

Check if I qualify

Extracted eligibility criteria

Treatments studied

Immunotherapy

Cemiplimab

Targeted therapy

Cetuximab

Cancer type

Head and Neck Squamous Cell Carcinoma

Biomarker criteria

Required: HPV wild-type (absence)

Performance status

ECOG 0–1(Restricted strenuous activity)

Prior therapy

Must have received: surgery — curative-intent

Must have received: radiation therapy — curative-intent

Lab requirements

Blood counts

hemoglobin ≥ 9 g/dl (transfusions permitted); absolute neutrophil count ≥ 1 x 10^9/ml; platelets ≥ 80 x 10^9/ml

Kidney function

creatinine clearance ≥ 30 ml/min as assessed by the cockcroft-gault equation

Liver function

ast and alt ≤ 3 x uln; total bilirubin ≤ 1.5 x uln or ≤ 3.0 x uln and primarily unconjugated if subject has a documented history of gilbert's syndrome or genetic equivalent

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • MD Anderson Cancer Center · Houston, Texas

Showing up to 5 US sites.

See all sites on ClinicalTrials.gov →

Frequently asked questions

Is NCT06448026 currently recruiting?

Yes, this trial is currently recruiting patients.

Is prior treatment required for enrollment?

Yes. Patients must have previously received surgery and radiation therapy.

Does this trial require HPV?

Yes, HPV wild-type is a required biomarker for enrollment.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify